MedTrace Logo

Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD)

NCT01990937 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2014-10-29

No results posted yet for this study

Summary

Can oral midazolam used for sedation in patients undergoing upper gastrointestinal endoscopy ?

Conditions

  • Conscious Sedation Failure During Procedure

Interventions

DRUG

Oral midazolam

5 mg in 15 mL of apple juice, orally 30 minutes before undergoing EGD

Sponsors & Collaborators

  • Phramongkutklao College of Medicine and Hospital

    lead OTHER

Principal Investigators

  • Chaipichit Puttapitakpong, Doctor · Division of gastroentrology, Department of Medicine, Phramongkutklao hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01990937 on ClinicalTrials.gov